Peri-implant Tissues on Aesthetic Slim Abutment Galimplant (PSG)
(PSG)
Behavior of the Peri-implant Tissues on the Multiposition Abutment Straight Aesthetic Slim Anti-rotational Galimplant
1 other identifier
interventional
80
1 country
1
Brief Summary
This is a randomized, single-blind, split-mouth clinical trial to evaluate the performance of peri-implant tissues (bone and soft tissues) in conventionally loaded Galimplant implants, using a classic multi-position, anti-rotational abutment, comparing it to the new multi-abutment aesthetic slim anti-rotational placed both at the time of the implant surgery. To this end, 80 Galimplant implants with a diameter of 4 mm and 10 mm in length will be placed in areas of mature scarred post-extraction bone. Patients be divided into 2 study groups, group C: straight pillar; Group T: Slim pillar. The bone and clinical radiological stability of the peri-implant tissues will be evaluated at 6 weeks post-surgery and at 6-12-24 months post-prosthetic loading.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2019
CompletedFirst Posted
Study publicly available on registry
January 8, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2020
CompletedDecember 2, 2024
March 1, 2020
1 month
January 3, 2019
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary stability of implants and peri-implant tissues
Randomly and following the inclusion and exclusion criteria, the implants will be placed with the normal preparation protocol. Investigators will evaluate the immediate post-surgical stability of implants and peri-implant tissues through the Ostell system, based on the resonance frequency analysis (RFA). The implant stability quotient (ISQ) is the value on a scale that indicates the level of stability and osseointegration in dental implants. The scale ranges from 1 to 100, with higher values indicating greater stability. The acceptable stability range lies between 55-85 ISQ
10 months
Secondary Outcomes (6)
Basal Peri-implant tissue level: implant stability
1 day
Basal Radiological Bone Implant level
1 day
Basal Peri-implant tissue level: probing depth
1 day
Radiological bone implant stability
8 weeks
Peri-implant tissue stability: probing depth
8 weeks
- +1 more secondary outcomes
Other Outcomes (6)
6-months clinical evaluation of probing depth
6 months
6-months ISQ evaluation
6 months
6-months radiological evaluation of definitive prostheses
6 months
- +3 more other outcomes
Study Arms (2)
Control Group
ACTIVE COMPARATORThe control group is considered, using the company's classic multi-position straight anti-rotational abutment
Test group
EXPERIMENTALThe test group is considered, where the new multi-position straight esthetic anti-rotational slim abutment is used
Interventions
This is the classic abutment, straight and anti-rotational for dental implants which have been tested before
This is the new concept of the prostheses abutment, slim and anti-rotational to improve the width of biologic space
Eligibility Criteria
You may qualify if:
- Patients without systemic pathology that are grounds for absolute contraindication
- Older adults who agree to be part of the study and sign the informed consent
- Consumption of tobacco less than 5 cigarettes / day
- Do not be completely toothless
- Absences of at least two pieces in posterior area with or without free ends to distal, maxillary or mandibular that do not require regenerative techniques. In case of odd absences (3,5,7), a Slim pillar will be placed, being the group to always be the majority.
- Area of mature bone healed at least 6 months post-extraction.
- Patients with a sufficient amount of bone to place implants 4 mm in diameter and 10 mm long
You may not qualify if:
- Immunosuppressed
- Aesthetic edentulous areas of 13-23 and 33-43
- Smokers of more than 5 cigarettes
- Index of bleeding greater than 30%
- Patients with less than 2 mm of keratinized gingiva
- Implants with primary stability with ISQ \<55
- Implants with ISQ index \<55 at 8 weeks
- When a margin of safety can not be assumed to the inferior dental nerve of at least 1 mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Santiago de Compostelalead
- Galimplant Dental Implantscollaborator
Study Sites (1)
Mario Pérez Sayáns
Santiago de Compostela, A Coruña, 15785, Spain
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Mario Perez Sayans MD, PhD (Principal investigator)
Study Record Dates
First Submitted
January 3, 2019
First Posted
January 8, 2019
Study Start
March 1, 2019
Primary Completion
April 1, 2019
Study Completion
January 8, 2020
Last Updated
December 2, 2024
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- Time Frame:
- Access Criteria
- under request
We will anonymize and categorize the clinical and radiological data of the patients to share the information with the other researchers of the group